头颈癌计划剂量与交付剂量推导的正常组织并发症概率模型比较
该回顾性研究纳入322例每日CBCT引导放疗的头颈癌患者,通过形变累积CBCT剂量估算交付剂量,比较基于计划剂量与交付剂量构建的Lyman-Kutcher-Burman NTCP模型。结果显示,尽管有毒性患者计划与交付EUO差异更大,但两组NTCP曲线陡度、数据吻合度及AUC差异均无统计学意义(AUC差异<0.01),提示使用累积剂量构建NTCP模型的额外临床价值可能有限。
要点
- 计划与交付EUO差异在有急性/晚期吞咽困难毒性患者中显著更大。
- 基于交付剂量与计划剂量的NTCP曲线参数差异小且无统计学意义。
- 两组模型AUC差异小于0.01,累积剂量对NTCP模型临床价值有限。
核心结论
- 计划剂量与交付剂量之间的差异未导致NTCP曲线出现显著差异。
- 使用累积剂量构建口腔黏膜炎、口干和吞咽困难的NTCP模型,其额外临床相关性可能有限。
研究设计与样本
- 回顾性研究纳入322例接受每日CBCT引导放疗的头颈癌患者。
- 通过将每日CBCT剂量形变累积至计划解剖结构来估算交付剂量。
- 采用Lyman-Kutcher-Burman NTCP模型,将危及器官的等效均匀剂量与口腔黏膜炎、口干和吞咽困难关联。
主要发现
- 计划与交付EUO的中位差异在伴有急性吞咽困难(≥G2和≥G3)及晚期吞咽困难(≥G3)的患者中显著大于无毒性患者(p<0.05)。
- 交付剂量与计划剂量拟合的NTCP曲线在陡度和数据吻合度上差异小且无统计学意义。
- 两组模型的AUC差异小于0.01。
临床怎么用
- 对于头颈癌放疗中口腔黏膜炎、口干和吞咽困难的NTCP建模,基于计划剂量与基于累积交付剂量的模型性能差异很小。
- 在临床实践中,使用累积剂量构建NTCP模型以提升预测价值的额外获益可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Normal tissue complication probability (NTCP) models are typically derived from the planned dose distribution, which can deviate from the delivered dose due to anatomical day-to-day variations. The aim of this study was to compare NTCP models derived from the planned and the delivered dose for head and neck cancer (HNC) patients. MATERIAL AND METHOD: 322 HNC patients who received radiotherapy with daily CBCT guidance were included in this retrospective study. The delivered dose was estimated by deformably accumulating dose from daily CBCT to planning anatomy. We used a Lyman-Kutcher-Burman NTCP model, to relate the equivalent uniform dose (EUD) of organs at risk (OAR) with oral mucositis, xerostomia and dysphagia respectively. We compared the model parameters and performances. RESULTS: The median differences between planned and delivered EUD to the OARs were significantly larger for patients with toxicity than without for acute dysphagia (≥G2 and ≥G3) and late dysphagia (≥G3) (p < 0.05). Those differences resulted in small differences in steepness and agreement to the data between delivered- and planned-fitted NTCP curves, and the differences were not significant. The differences in AUC were less than 0.01. CONCLUSION: Differences between delivered and planned dose did not lead to significant differences in NTCP curves. The additional clinical relevance of NTCP models using accumulated dose for oral mucositis, xerostomia and dysphagia in HNC radiotherapy is likely to be limited.
引用
- Kanehira T, van Kranen S, Jansen T, et al. Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients. Radiother Oncol. 2021. PMID: 34619234. doi:10.1016/j.radonc.2021.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。